Fig. 3.

Decellularization treatment affects ECM components, assessed by histology proteomics assays. A) Principal component analysis of proteomic data. The analysis groups separately each treatment (n = 2 per treatment), B) Total number of unique proteins observed in each treatment, C) Venn diagram of common proteins observed among different decellularization treatments and compared to control initial samples, D-E) Heat map representation of, D) All detected proteins and, E) selected proteins including collagens and cell adhesion molecules.